247 related articles for article (PubMed ID: 27166155)
1. Downregulated long non-coding RNA MEG3 in breast cancer regulates proliferation, migration and invasion by depending on p53's transcriptional activity.
Sun L; Li Y; Yang B
Biochem Biophys Res Commun; 2016 Sep; 478(1):323-329. PubMed ID: 27166155
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA MEG3 suppresses breast cancer cell proliferation, invasion, and angiogenesis through AKT pathway.
Zhang CY; Yu MS; Li X; Zhang Z; Han CR; Yan B
Tumour Biol; 2017 Jun; 39(6):1010428317701311. PubMed ID: 28635399
[TBL] [Abstract][Full Text] [Related]
3. Long Noncoding RNA MEG3 Interacts with p53 Protein and Regulates Partial p53 Target Genes in Hepatoma Cells.
Zhu J; Liu S; Ye F; Shen Y; Tie Y; Zhu J; Wei L; Jin Y; Fu H; Wu Y; Zheng X
PLoS One; 2015; 10(10):e0139790. PubMed ID: 26444285
[TBL] [Abstract][Full Text] [Related]
4. Long Non-Coding RNA HOTAIR Regulates the Proliferation, Self-Renewal Capacity, Tumor Formation and Migration of the Cancer Stem-Like Cell (CSC) Subpopulation Enriched from Breast Cancer Cells.
Deng J; Yang M; Jiang R; An N; Wang X; Liu B
PLoS One; 2017; 12(1):e0170860. PubMed ID: 28122024
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA MEG3 inhibits NSCLC cells proliferation and induces apoptosis by affecting p53 expression.
Lu KH; Li W; Liu XH; Sun M; Zhang ML; Wu WQ; Xie WP; Hou YY
BMC Cancer; 2013 Oct; 13():461. PubMed ID: 24098911
[TBL] [Abstract][Full Text] [Related]
6. Long noncoding RNA MEG3 inhibits breast cancer growth via upregulating endoplasmic reticulum stress and activating NF-κB and p53.
Zhang Y; Wu J; Jing H; Huang G; Sun Z; Xu S
J Cell Biochem; 2019 Apr; 120(4):6789-6797. PubMed ID: 30556250
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of the long non-coding RNA TUG1 is associated with cell proliferation, migration, and invasion in breast cancer.
Fan S; Yang Z; Ke Z; Huang K; Liu N; Fang X; Wang K
Biomed Pharmacother; 2017 Nov; 95():1636-1643. PubMed ID: 28950664
[TBL] [Abstract][Full Text] [Related]
8. Long Non-Coding RNA MEG3 Downregulation Triggers Human Pulmonary Artery Smooth Muscle Cell Proliferation and Migration via the p53 Signaling Pathway.
Sun Z; Nie X; Sun S; Dong S; Yuan C; Li Y; Xiao B; Jie D; Liu Y
Cell Physiol Biochem; 2017; 42(6):2569-2581. PubMed ID: 28848087
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA MEG3 regulates LATS2 by promoting the ubiquitination of EZH2 and inhibits proliferation and invasion in gallbladder cancer.
Jin L; Cai Q; Wang S; Wang S; Mondal T; Wang J; Quan Z
Cell Death Dis; 2018 Oct; 9(10):1017. PubMed ID: 30282996
[TBL] [Abstract][Full Text] [Related]
10. LncRNA MEG3 inhibits cell epithelial-mesenchymal transition by sponging miR-421 targeting E-cadherin in breast cancer.
Zhang W; Shi S; Jiang J; Li X; Lu H; Ren F
Biomed Pharmacother; 2017 Jul; 91():312-319. PubMed ID: 28463794
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of CCAT2 promotes cell proliferation by repressing the P15 in breast cancer.
Deng X; Zhao Y; Wu X; Song G
Biomed Pharmacother; 2017 Jul; 91():1160-1166. PubMed ID: 28531944
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic repression of long non-coding RNA MEG3 mediated by DNMT1 represses the p53 pathway in gliomas.
Li J; Bian EB; He XJ; Ma CC; Zong G; Wang HL; Zhao B
Int J Oncol; 2016 Feb; 48(2):723-33. PubMed ID: 26676363
[TBL] [Abstract][Full Text] [Related]
13. MEG3, HCN3 and linc01105 influence the proliferation and apoptosis of neuroblastoma cells via the HIF-1α and p53 pathways.
Tang W; Dong K; Li K; Dong R; Zheng S
Sci Rep; 2016 Nov; 6():36268. PubMed ID: 27824082
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA Loc554202 regulates proliferation and migration in breast cancer cells.
Shi Y; Lu J; Zhou J; Tan X; He Y; Ding J; Tian Y; Wang L; Wang K
Biochem Biophys Res Commun; 2014 Apr; 446(2):448-53. PubMed ID: 24631686
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of long non-coding RNA ROR reverses resistance to Tamoxifen by inducing autophagy in breast cancer.
Li Y; Jiang B; Zhu H; Qu X; Zhao L; Tan Y; Jiang Y; Liao M; Wu X
Tumour Biol; 2017 Jun; 39(6):1010428317705790. PubMed ID: 28635401
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of LncRNA MEG3 inhibits cell migration and invasion and enhances cisplatin chemosensitivity in bladder cancer cells.
Feng SQ; Zhang XY; Fan HT; Sun QJ; Zhang M
Neoplasma; 2018 Nov; 65(6):925-932. PubMed ID: 29940769
[TBL] [Abstract][Full Text] [Related]
17. The Long Noncoding RNA MEG3 Contributes to Cisplatin Resistance of Human Lung Adenocarcinoma.
Liu J; Wan L; Lu K; Sun M; Pan X; Zhang P; Lu B; Liu G; Wang Z
PLoS One; 2015; 10(5):e0114586. PubMed ID: 25992654
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA MEG3 is downregulated in cervical cancer and affects cell proliferation and apoptosis by regulating miR-21.
Zhang J; Yao T; Wang Y; Yu J; Liu Y; Lin Z
Cancer Biol Ther; 2016; 17(1):104-13. PubMed ID: 26574780
[TBL] [Abstract][Full Text] [Related]
19. Long noncoding RNA MEG3 activation of p53 mediates ischemic neuronal death in stroke.
Yan H; Yuan J; Gao L; Rao J; Hu J
Neuroscience; 2016 Nov; 337():191-199. PubMed ID: 27651151
[TBL] [Abstract][Full Text] [Related]
20. Down-regulation of MEG3, PANDA and CASC2 as p53-related lncRNAs in breast cancer.
Ghafouri-Fard S; Sohrabi B; Hussen BM; Mehravaran E; Jamali E; Arsang-Jang S; Fathi M; Taheri M; Samsami M
Breast Dis; 2022; 41(1):137-143. PubMed ID: 35034894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
